Diagnostic value of ganglion cell-inner plexiform layer for early detection of ethambutol-induced optic neuropathy.
Lee Ju-Yeun, Han Jinu, Seo Jeong Gi, Park Kyung-Ah, Oh Sei Yeul
AI Summary
Macular GCIPL thickness, particularly minimum GCIPL, outperforms pRNFL for early detection of ethambutol-induced optic neuropathy, offering a superior diagnostic tool for this challenging condition.
Abstract
Aim
To evaluate the diagnostic value of macular ganglion cell-inner plexiform layer (mGCIPL) thickness versus peripapillary retinal nerve fibre layer (pRNFL) thickness for the early detection of ethambutol-induced optic neuropathy (EON).
Methods
Twenty-eight eyes of 15 patients in the EON group and 100 eyes of 53 healthy subjects in the control group were included. All patients with EON demonstrated the onset of visual symptoms within 3 weeks. Diagnostic power for pRNFL and mGCIPL thicknesses measured by Cirrus spectral-domain optical coherence tomography was assessed by area under the receiver operating characteristic (AUROC) curves and sensitivity.
Results
All of the mGCIPL thickness measurements were thinner in the EON group than in the control group in early EON (p<0.001). All of pRNFL thicknesses except inferior RNFL showed AUROC curves above 0.5, and all of the mGCIPL thicknesses showed AUROC curves above 0.5. The AUROC of the average mGCIPL (0.812) thickness was significantly greater than that of the average pRNFL (0.507) thickness (p<0.001). Of all the mGCIPL-related parameters considered, the minimum thickness showed the greatest AUROC value (0.863). The average mGCIPL thickness showed a weak correlation with visual field pattern standard deviations (r 2 =0.158, p<0.001).
Conclusions
In challenging cases of EON, the mGCIPL thickness has better diagnostic performance in detecting early-onset EON as compared with using pRNFL thickness. Among the early detection ability of mGCIPL thickness, minimum GCIPL thickness has high diagnostic ability.
MeSH Terms
Shields Classification
Key Concepts5
Macular ganglion cell-inner plexiform layer (mGCIPL) thickness measurements were significantly thinner in 28 eyes of 15 patients with ethambutol-induced optic neuropathy (EON) compared to 100 eyes of 53 healthy subjects in a cross-sectional study (p<0.001).
The area under the receiver operating characteristic (AUROC) curve for average macular ganglion cell-inner plexiform layer (mGCIPL) thickness (0.812) was significantly greater than that for average peripapillary retinal nerve fibre layer (pRNFL) thickness (0.507) for detecting early ethambutol-induced optic neuropathy (EON) in a cross-sectional study (p<0.001).
Among all macular ganglion cell-inner plexiform layer (mGCIPL)-related parameters, the minimum mGCIPL thickness showed the greatest area under the receiver operating characteristic (AUROC) value (0.863) for detecting early ethambutol-induced optic neuropathy (EON) in a cross-sectional study.
Average macular ganglion cell-inner plexiform layer (mGCIPL) thickness showed a weak correlation with visual field pattern standard deviations (r^2 = 0.158, p<0.001) in patients with ethambutol-induced optic neuropathy (EON) in a cross-sectional study.
A cross-sectional study included 28 eyes of 15 patients with ethambutol-induced optic neuropathy (EON) and 100 eyes of 53 healthy subjects to evaluate the diagnostic value of macular ganglion cell-inner plexiform layer (mGCIPL) thickness versus peripapillary retinal nerve fibre layer (pRNFL) thickness for early EON detection.
Related Articles5
Longitudinal Changes of Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer in Highly Myopic Glaucoma: A 3-Year Cohort Study.
Cohort StudyIndependent Evaluation of RETFound Foundation Model's Performance on Optic Nerve Analysis Using Fundus Photography.
Observational StudyProximal Location of Optic Disc Hemorrhage and Glaucoma Progression.
Cohort StudyPrediction of Visual Field Progression with Baseline and Longitudinal Structural Measurements Using Deep Learning.
Observational StudyNumber of macula optical coherence tomography scans needed to detect glaucoma progression.
Cohort StudyIs this article assigned to the wrong chapter(s)? Let us know.